Tasyurek, H. Et Al. 2015. Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment.. European Society of Gene and Cell Therapy (ESGCT) and Finnish Society of Gene Therapy (FSGT) Collaborative Congress. Human Gene Therapy. , (Helsinki, Finland).

Tasyurek, H., Altunbaş , H., CANATAN, H., & Sanlioglu, S., (2015). Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment. . European Society of Gene and Cell Therapy (ESGCT) and Finnish Society of Gene Therapy (FSGT) Collaborative Congress. Human Gene Therapy., Helsinki, Finland

Tasyurek, HA Et Al. "Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment.," European Society of Gene and Cell Therapy (ESGCT) and Finnish Society of Gene Therapy (FSGT) Collaborative Congress. Human Gene Therapy., Helsinki, Finland, 2015

Tasyurek, HA Et Al. "Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment.." European Society of Gene and Cell Therapy (ESGCT) and Finnish Society of Gene Therapy (FSGT) Collaborative Congress. Human Gene Therapy. , Helsinki, Finland, 2015

Tasyurek, H. Et Al. (2015) . "Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment.." European Society of Gene and Cell Therapy (ESGCT) and Finnish Society of Gene Therapy (FSGT) Collaborative Congress. Human Gene Therapy. , Helsinki, Finland.

@conferencepaper{conferencepaper, author={HA Tasyurek Et Al. }, title={Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment.}, congress name={European Society of Gene and Cell Therapy (ESGCT) and Finnish Society of Gene Therapy (FSGT) Collaborative Congress. Human Gene Therapy.}, city={Helsinki}, country={Finland}, year={2015}}